InvestorsHub Logo
Followers 13
Posts 547
Boards Moderated 0
Alias Born 12/23/2020

Re: chumppunk post# 220420

Wednesday, 05/24/2023 8:32:53 AM

Wednesday, May 24, 2023 8:32:53 AM

Post# of 233149
That seems very possible!!!

CenterWatch.com/clinical-trials/listings 218732 Pro14
Pro140 in treatment experienced HIV-1 Subjects
Participants: 25
Status: (Not recruiting)
Updated on: 23rd May/2023
DETAILS:
Condition: HIV-1-infection
Treatment: Pro140
Clinical study
Identifier: NCT03902522
Sponsor: Cytodyn, Inc.....Last modified: 23 May 2023
SUMMARY:
The primary objectives of the trial are to assess the EfficacyClinical Safety and Tolerability parameters of PRO140 in combination with failing ART during the initial one-week treatment period and in combination with Optimized Background Therapy during the subsequent 24-week treatment period.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News